Breaking News

GBI Biomanufacturing Adds Automated Aseptic Fill-Finish Capabilities

New three format automated filler has capabilities to support filling in vials, syringes and cartridges, across various drug classes.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

GBI Biomanufacturing (GBI), a CDMO, is expanding its Drug Product (DP) services to include automated sterile fill and finish capabilities. GBI supports clients from clinical trials to commercial launch, for both Drug Substance (DS) and DP, at its location in Plantation, FL. This expansion aims to deliver advanced and flexible Single-Source Solutions for the pharmaceutical and biotech industries.   The ability to provide an in-house, dual approach of automated and manual sterile fill finish, en...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters